MEDIX RESOURCES INC
NT 10-Q, 2000-05-16
HELP SUPPLY SERVICES
Previous: DEVELOPED TECHNOLOGY RESOURCE INC, NT 10-Q, 2000-05-16
Next: HA LO INDUSTRIES INC, S-3/A, 2000-05-16




                                   Form 12b-25

                                                                 SEC FILE NUMBER
                                                                         0-19333

                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20459

                                   FORM 12B-25

                           NOTIFICATION OF LATE FILING

                                  (Check One):

[ ]Form 10-K and 10-KSB [ ]Form 20-F [ ]Form 11-K [X]Form 10-QSB [ ]Form N-SAR

         For Period Ended:  March 31, 2000
         [ ] Transition Report on Form 10-K
         [ ] Transition Report on Form 20-F
         [ ] Transition Report on Form 11-K
         [ ] Transition Report on Form 10-Q
         [ ] Transition Report on Form N-SAR
         For the Transition Period Ended:

Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification related to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

Part I-Registrant Information

        MEDIX RESOURCES, INC.
        (Full name of Registrant)
        ----------------------------------------
        7100 E BELLEVIEW AVENUE, SUITE 301
        (Address of Principal Executive Office)
        ----------------------------------------
        ENGLEWOOD, COLORADO   80111
        (City State Zip)

Part II.Rules 12b.25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b.25(b), the following should
be completed. (Check box if appropriate)

        (a) The reasons described in reasonable detail in Part III of this form
            could not be eliminated without unreasonable effort or expense;

  X     (b) The subject annual report, semi-annual report, transition report on
            Form 10.K, Form 10-KSB, Form 20-F, 11.K or Form N.SAR, or portion
            thereof will be filed on or before the fifteenth calendar day
            following the prescribed due date; or the subject quarterly report
            or transition report on Form 10.Q or Form 10-QSB, or portion thereof
            will be filed on or before the fifth calendar day following the
            prescribed due date; and

        (c) The accountant's statement or other exhibit required by Rule
            12b.25(c) has been attached if applicable.


<PAGE>



Part III. Narrative

State below in reasonable detail the reasons why Form 10-K and 10-KSB, 20-F,
11-K, 10-Q and 10-QSB, N-SAR or the transition report or portion thereof could
not be filed within the prescribed time period.

         More time is needed to accumulate information.

Part IV. Other Information

        (1) Name and telephone number of person to contact in regard to this
            notification

                 Lyle B. Stewart              (303)                741-2045
                     (Name)                (Area Code)        (Telephone Number)

        (2) Have all other periodic reports required under section 13 or 15(d)
            of the Securities Exchange Act of 1934 or section 30 of the
            Investment Company Act of 1940 during the preceding 12 months or for
            such shorter period that the registrant was required to file such
            report(s) been filed?  If the answer is no, identify report(s).
                                                   [X] Yes            [ ] No

        (3) Is it anticipated that any significant change in results of
            operations from the corresponding period for the last fiscal year
            will be reflected by the earnings statements to be included in the
            subject report or portion thereof?
                                                   [ ] Yes            [X] No

If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

                              MEDIX RESOURCES, INC.

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date May 15, 2000                        /s/ Patricia A. Minicucci,
                                             Executive Vice President


INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission